Pharmacokinetics and Dosimetry of [ <sup>68</sup> Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study
The pharmacokinetic and dosimetry profiles of [<sup>68</sup>Ga]Ga-PSMA-11, assessed using a validated method in participants with progressive mCRPC, make it very suitable as an imaging agent.
Authors
- Z. W. Yang (ORCID: https://orcid.org/0000-0003-4371-1032)
- Zhigang Ji (ORCID: https://orcid.org/0000-0003-3834-6579)
- Yong Li (ORCID: https://orcid.org/0000-0003-4038-0493)
- Haifu Li (ORCID: https://orcid.org/0009-0007-1573-3433)
- H. Z. Shi (ORCID: https://orcid.org/0000-0002-8014-2783)
- Jianming Guo (ORCID: https://orcid.org/0009-0009-6535-9317)
- Xinlu Wang
- Yi-Xiang Wang (ORCID: https://orcid.org/0000-0002-4021-4228)
- Runqin Li
- R. Huang
- Feng Wang
- Danfeng Xu
- Zhi Yang
- Dingwei Ye
- Di Gu
- Zhiqiang Jiang
- Wei Fan
- Jialu Li
- Li Huo
- Qiang Dong
Institutions
- Sun Yat-sen University (CN)
- Shanghai Jiao Tong University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Sichuan University (CN)
- Fudan University (CN)
- Peking Union Medical College Hospital (CN)
- Ruijin Hospital (CN)
- West China Hospital of Sichuan University (CN)
- Novartis (China) (CN)
- Fudan University Shanghai Cancer Center (CN)
- Peking University Cancer Hospital (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
- Xijing Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Cancer Biotherapy and Radiopharmaceuticals
- Published
- 2026-02-14
- DOI
- https://doi.org/10.1177/10849785251415122
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00